Join Us

We are 224,965 members in 83 forums discussing 163,804 topics.

Help with Abbreviations

Topic: Experimental Tucatinib Improves Survival in HER2+ MBC

Forum: Stage IV/Metastatic Breast Cancer, Open to All To Contribute —

Topics here are started by members with a Stage IV/Metastatic Breast Cancer diagnosis, but open to all members to contribute to discussions. Please note that there is a separate forum, Stage IV/Metastatic Breast Cancer ONLY, where topics are open only to those members.

Posted on: Dec 18, 2019 04:44AM

Moderators wrote:

Experimental Tucatinib Improves Survival in Metastatic HER2-Positive Breast Cancer, May Be New Standard of Care
December 17, 2019

Adding experimental tucatinib to the standard of care of Herceptin and Xeloda improved both progression-free survival and overall survival in people diagnosed with metastatic HER2-positive breast cancer that had been previously treated with Herceptin, Perjeta, and Kadcyla. Read more...

To send a Private Message to the Mods:
Log in to post a reply